Susquehanna International Group, LLP Biotechnology

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
AKBA
Akebia Therapeutics, Inc.
CALL
$130,000
98.9K
Q3 2024
Reduced 33.86%
CGEN
Compugen LTD
CALL
$123,000
68.3K
Q1 2024
Reduced 27.25%
PGEN
Precigen, Inc.
CALL
$121,000
127K
Q3 2024
Reduced 64.86%
ZNTL
Zentalis Pharmaceuticals, Inc.
PUT
$121,000
33K
Q3 2024
Added 174.74%
MRVI
Maravai Lifesciences Holdings, Inc.
PUT
$117,000
14.1K
Q3 2024
Reduced 87.86%
ALLO
Allogene Therapeutics, Inc.
CALL
$114,000
41K
Q3 2024
Reduced 6.02%
SVRA
Savara Inc
CALL
$114,000
26.9K
Q3 2024
Reduced 28.11%
ATOS
Atossa Therapeutics, Inc.
PUT
$108,000
71.1K
Q3 2024
New holding
CVM
Cel Sci Corp
PUT
$106,000
101K
Q3 2024
Reduced 17.93%
ZNTL
Zentalis Pharmaceuticals, Inc.
CALL
$105,000
28.8K
Q3 2024
Added 174.74%
HRTX
Heron Therapeutics, Inc.
PUT
$102,000
51.5K
Q3 2024
Reduced 60.12%
CDXC
Chroma Dex Corp.
CALL
$101,000
27.8K
Q3 2024
New holding
VTYX
Ventyx Biosciences, Inc.
PUT
$98,000
45.1K
Q3 2024
Added 109.12%
CRDF
Cardiff Oncology, Inc.
PUT
$97,000
36.5K
Q2 2024
Reduced 56.79%
AMRN
Amarin Corp Plcuk
CALL
$95,000
152K
Q3 2024
Added 85.72%
ALXO
Alx Oncology Holdings Inc
CALL
$94,000
52.1K
Q3 2024
Added 23.56%
TBPH
Theravance Biopharma, Inc.
PUT
$93,000
11.6K
Q3 2024
Reduced 26.94%
FGEN
Fibrogen Inc
CALL
$92,000
230K
Q3 2024
Reduced 88.54%
EPIX
Essa Pharma Inc.
CALL
$91,000
15.1K
Q3 2023
Added 93.33%
XFOR
X4 Pharmaceuticals, Inc
CALL
$91,000
137K
Q3 2024
Added 58.93%
ETON
Eton Pharmaceuticals, Inc.
CALL
$90,000
15K
Q3 2024
Reduced 11.13%
MRSN
Mersana Therapeutics, Inc.
PUT
$88,000
46.8K
Q3 2024
Reduced 31.28%
PYXS
Pyxis Oncology, Inc.
CALL
$87,000
23.8K
Q3 2024
Reduced 25.82%
RPHM
Reneo Pharmaceuticals, Inc.
CALL
$86,000
50.8K
Q2 2024
Added 549.73%
VXRT
Vaxart, Inc.
PUT
$80,000
94.2K
Q3 2024
Reduced 26.2%
HRTX
Heron Therapeutics, Inc.
CALL
$79,000
40.2K
Q3 2024
Reduced 60.12%
VXRT
Vaxart, Inc.
CALL
$79,000
94.1K
Q3 2024
Reduced 26.2%
TPST
Tempest Therapeutics, Inc.
PUT
$76,000
54.7K
Q3 2024
New holding
DSGN
Design Therapeutics, Inc.
PUT
$74,000
13.8K
Q2 2024
Added 93.43%
ENOB
Enochian Biosciences Inc
PUT
$74,000
16.1K
Q3 2024
New holding
CSBR
Champions Oncology, Inc.
PUT
$73,000
15K
Q3 2019
Closed
MCRB
Seres Therapeutics, Inc.
CALL
$73,000
77.2K
Q3 2024
Reduced 16.46%
SVRA
Savara Inc
PUT
$72,000
17.1K
Q3 2024
Reduced 28.11%
TSVT
2seventy Bio, Inc.
PUT
$70,000
15K
Q2 2024
Added 27.07%
MRSN
Mersana Therapeutics, Inc.
CALL
$70,000
37.5K
Q3 2024
Reduced 31.28%
ENOB
Enochian Biosciences Inc
CALL
$70,000
15.3K
Q3 2024
New holding
STRO
Sutro Biopharma, Inc.
PUT
$70,000
20.3K
Q3 2024
Added 31.76%
CMRX
Chimerix Inc
PUT
$68,000
73.9K
Q3 2024
Added 10.6%
PRQR
Pro Qr Therapeutics N.V.
CALL
$68,000
37.4K
Q3 2024
Reduced 56.07%
BLUE
Bluebird Bio, Inc.
PUT
$66,000
129K
Q3 2024
Reduced 39.95%
RVNC
Revance Therapeutics, Inc.
PUT
$65,000
25.3K
Q3 2024
Reduced 68.0%
VNDA
Vanda Pharmaceuticals Inc.
CALL
$65,000
13.9K
Q3 2024
Reduced 49.83%
VERV
Verve Therapeutics, Inc.
CALL
$65,000
13.6K
Q3 2024
Reduced 61.67%
GOSS
Gossamer Bio, Inc.
CALL
$63,000
64.1K
Q3 2024
Added 5.21%
VNDA
Vanda Pharmaceuticals Inc.
PUT
$58,000
12.5K
Q3 2024
Reduced 49.83%
RGLS
Regulus Therapeutics Inc.
CALL
$57,000
36.4K
Q1 2024
New holding
AVTE
Aerovate Therapeutics, Inc.
PUT
$53,000
25.7K
Q2 2024
New holding
ABOS
Acumen Pharmaceuticals, Inc.
PUT
$52,000
21.1K
Q3 2024
Reduced 0.11%
ERAS
Erasca, Inc.
CALL
$50,000
18.6K
Q3 2024
Added 20.11%
Filter Shares Options
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email